3709 results for «200»
3709 results
Managing difficult TAVI scenarios
19 May 2026 – From EuroPCR 2026
Focused on complex TAVI cases, this session reviews guideline recommendations for TAVI in younger patients, strategies for managing concomitant coronary artery disease, and considerations for treating asymptomatic severe aortic stenosis. Real-world cases illustrate clinical decision-making and outcomes.
TAVI procedural complications - Part 1: VSD, valve embolisation, and more
19 May 2026 – From EuroPCR 2026
This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.
Improving interventional care and occupational safety
19 May 2026 – From EuroPCR 2026
This session addresses advancements in interventional cardiology care quality and occupational safety. Key topics include patient-centered care perspectives, optimized catheterization lab scheduling, the impact of procedural volumes on outcomes, and innovations in radiation protection technologies.
How to prevent and manage complex and complicated LAA closure cases?
19 May 2026 – From EuroPCR 2026
Designed to enhance procedural success in transcatheter left atrial appendage closure, this session addresses identification of complex anatomies, management of intraprocedural challenges, and strategies to prevent and handle complications, illustrated by practical case examples and expert evaluations.
Beyond valves: expanding the structural toolbox
19 May 2026 – From EuroPCR 2026
This session expands the scope of structural heart interventions beyond valve therapies. It covers embolic protection in high-risk intracardiac procedures, outcomes of paravalvular leak closures, novel aortic root stent-graft research, cerebral ischemia predictors after TEVAR, and transcatheter ASD closure techniques.
How should I treat a patient with a calcified mitral anatomy?
19 May 2026 – From EuroPCR 2026
This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.
Angiography-based physiology in clinical practice
19 May 2026 – From EuroPCR 2026
Investigate the clinical application of angiography-based physiology in coronary artery disease management. This session covers quantitative flow ratio (QFR) guided PCI strategies, risk stratification in chronic coronary syndrome, and prognostic value of angiography-derived indices, offering a wire-free diagnostic approach supported by recent trial data.
Optimal management of primary PCI complications
19 May 2026 – From EuroPCR 2026
This session delves into the optimal management of complications arising during primary PCI. It addresses critical scenarios from initial hesitation and unexpected challenges to confident treatment strategies for vessel complications. Notably, it explores complex cases such as paradoxical embolisation following rescue PCI in STEMI patients, providing...
Risk stratification and drug therapies in coronary arteries interventions
19 May 2026 – From EuroPCR 2026
This session offers a detailed examination of risk stratification and pharmacologic therapies in coronary artery interventions. It features innovative markers such as left ventricle filling pressure (E/E' ratio) for predicting myocardial injury, clinical outcome impacts in dialysis-dependent patients, intraoperative DOAC removal during CABG, and machine learning...
High-risk PCI: how to optimise the result
19 May 2026 – From EuroPCR 2026
Focused on high-risk PCI, this session presents strategies to optimize procedural outcomes in complex cases. Discussions include contemporary approaches to challenging coronary anatomy, the role of balloon aortic valvuloplasty as a bridge to Impella-supported interventions, advanced mechanical support and thrombectomy in cardiogenic shock related to left...
Choosing the right tool to treat calcified bifurcation
19 May 2026 – From EuroPCR 2026
This session provides expert guidance on managing calcified bifurcation lesions. It highlights identification of high-risk scenarios, the role of coronary CT angiography and intravascular imaging in tool selection, and specialized techniques for treating calcified nodules in the left main coronary artery.
Major Late-Breaking Trials from EuroPCR 2026
20 May 2026 – From EuroPCR 2026
This session presents major late-breaking trials from EuroPCR 2026, reviewing contemporary evidence on coronary revascularization in TAVI patients, long-term outcomes of PCI versus CABG for left main disease, and comparative effectiveness of LAA closure versus NOAC in atrial fibrillation across age groups, with clinical practice implications.
Outcomes in tricuspid valve intervention
19 May 2026 – From EuroPCR 2026
This session reviews contemporary clinical outcomes of tricuspid valve interventions. Topics include interim results from the Cardiovalve replacement system trial, the impact of atrial fibrillation on tricuspid TEER, residual regurgitation implications, afterload mismatch post-intervention, and long-term bioprosthetic valve durability.
Management of a patient with complex multivessel disease involving bifurcations
19 May 2026 – From EuroPCR 2026
Complex multivessel coronary disease involving bifurcations requires careful procedural planning, imaging guidance and tailored stent strategies.
This EuroPCR 2026 session combines live educational case with insights from the NAGOMI COMPLEX study to explore contemporary approaches to complex PCI. A key focus is placed on the role of...
How can we improve the management of aortic stenosis in 2026?
19 May 2026 – From EuroPCR 2026
As aortic stenosis management continues to evolve, this EuroPCR 2026 session looks ahead to the challenges and opportunities shaping clinical practice in 2026. From implementing the latest guidelines in daily care to refining the timing of intervention, the discussion focuses on how earlier identification and treatment...
From referral to discharge: European consensus on the TAVI care pathway
19 May 2026 – From EuroPCR 2026
Across Europe, TAVI programmes are under increasing pressure from rising demand, capacity limits and referral barriers. This EuroPCR 2026 session presents the European consensus on the TAVI care pathway and explores how data-driven, standardised approaches can optimise the patient journey from referral to discharge.
Bringing together clinicians,...
DCB in contemporary PCI: evidence, technique and physiology-guided decision-making
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores the evolving role of drug-coated balloons (DCB) in contemporary PCI, highlighting how growing clinical evidence, refined procedural strategies and physiology-guided tools are reshaping everyday practice.
The discussion reviews the latest data supporting DCB use, including long-term outcomes from major registries and trials...
Evolving bifurcation treatment practices: DCB, angio-based FFR and side branch optimisation
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores the evolving landscape of bifurcation PCI, focusing on drug-coated balloon (DCB) strategies, angio-based fractional flow reserve (FFR) and side branch optimisation. It highlights how new evidence and physiology-guided tools are reshaping decision-making in this complex lesion subset.
Discussions include insights from the...
Artificial intelligence-driven precision therapy for TAVI: progress and practice in China
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores the integration of artificial intelligence into precision therapy for TAVI in China, highlighting its growing role in procedural planning, optimisation and outcome prediction.
Through case-based discussion, it shows how AI-enabled tools can simulate valve deployment and visualise post-TAVR results, supporting more precise...
When less is better - Differentiated therapies to safely achieve TR 0-1+
19 May 2026 – From EuroPCR 2026
Therapeutic goals in tricuspid regurgitation are evolving, with increasing emphasis on achieving near-complete elimination of regurgitation (TR 0–1+) through differentiated transcatheter strategies.
This EuroPCR 2026 session explores how transcatheter edge-to-edge repair (TEER) and transcatheter tricuspid valve replacement (TTVR) can be used in a complementary way to reach...
